A Double-Blind, Placebo-Controlled Study of Brexpiprazole in the Treatment of Borderline Personality Disorder

BACKGROUND: Borderline personality disorder (BPD) is associated with impaired quality of life and has a number of untoward public health associations. There is no established first-line pharmacological treatment for BPD, and available options are not suitable for all individuals. AIMS: To evaluate B...

Descripción completa

Detalles Bibliográficos
Autores principales: Grant, Jon E., Valle, Stephanie, Chesivoir, Eve, Ehsan, Dustin, Chamberlain, Samuel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612273/
https://www.ncbi.nlm.nih.gov/pubmed/35049469
http://dx.doi.org/10.1192/bjp.2021.159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612273/
https://www.ncbi.nlm.nih.gov/pubmed/35049469
http://dx.doi.org/10.1192/bjp.2021.159

Ejemplares similares